Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe RheumatoId Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01706926
What this trial is testing

Mavrilimumab in Subjects With Moderate-to-Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
MedImmune LLC 420
Large-scale testing (Phase 3)Study completedNCT02265705
What this trial is testing

Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 290
Early research (Phase 1)Study completedNCT02717988
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Oscotec Inc. 48
Testing effectiveness (Phase 2)Study completedNCT01894516
What this trial is testing

Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2)

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 287
Large-scale testing (Phase 3)Study completedNCT01214733
What this trial is testing

RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 30
Large-scale testing (Phase 3)Study completedNCT04134728
What this trial is testing

Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 550
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Large-scale testing (Phase 3)Study completedNCT01721044
What this trial is testing

A Moderate to Severe Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 527
Not applicableStudy completedNCT01375478
What this trial is testing

An Observational Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 197
Testing effectiveness (Phase 2)Study completedNCT01404585
What this trial is testing

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 123
Post-approval studies (Phase 4)Study completedNCT03449758
What this trial is testing

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 84
Testing effectiveness (Phase 2)Ended earlyNCT01576549
What this trial is testing

LY2127399 in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 2
Not applicableStudy completedNCT01663506
What this trial is testing

A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 23
Large-scale testing (Phase 3)Study completedNCT01007435
What this trial is testing

Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 1,162
Testing effectiveness (Phase 2)Study completedNCT01554696
What this trial is testing

Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Inc 379
Large-scale testing (Phase 3)Study completedNCT00531817
What this trial is testing

Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 619
Large-scale testing (Phase 3)UnknownNCT04312815
What this trial is testing

A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX

Who this might be right for
Rheumatoid Arthritis(RA)
SinoMab BioScience Ltd 510
Post-approval studies (Phase 4)Study completedNCT01255761
What this trial is testing

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 736
Not applicableStudy completedNCT01667458
What this trial is testing

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Ended earlyNCT03329885
What this trial is testing

Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis

Who this might be right for
Rheumatoid ArthritisPsoriasisAnkylosing Spondylitis+2 more
Bristol-Myers Squibb 38
Next Page